Targeting innate immunity by blocking CD14: Novel approach to control inflammation and organ dysfunction in COVID-19 illness

Thomas R. Martin, Mark M. Wurfel, Ivan Zanoni, Richard Ulevitch

Open source

DOI
10.1016/j.ebiom.2020.102836
Published
2020-07
Container
EBioMedicine
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ebiom.2020.102836,
  title = {Targeting innate immunity by blocking CD14: Novel approach to control inflammation and organ dysfunction in COVID-19 illness},
  author = {Thomas R. Martin and Mark M. Wurfel and Ivan Zanoni and Richard Ulevitch},
  year = {2020},
  journal = {EBioMedicine},
  doi = {10.1016/j.ebiom.2020.102836},
  url = {https://doi.org/10.1016/j.ebiom.2020.102836}
}

RIS

TY  - JOUR
TI  - Targeting innate immunity by blocking CD14: Novel approach to control inflammation and organ dysfunction in COVID-19 illness
AU  - Thomas R. Martin
AU  - Mark M. Wurfel
AU  - Ivan Zanoni
AU  - Richard Ulevitch
PY  - 2020
JO  - EBioMedicine
DO  - 10.1016/j.ebiom.2020.102836
UR  - https://doi.org/10.1016/j.ebiom.2020.102836
ER  - 

APA

Martin, T. R., Wurfel, M. M., Zanoni, I., & Ulevitch, R. (2020). Targeting innate immunity by blocking CD14: Novel approach to control inflammation and organ dysfunction in COVID-19 illness. EBioMedicine. https://doi.org/10.1016/j.ebiom.2020.102836

Source records